Please enable Javascript
Amit Mahipal, MD
Amit Mahipal, MD, University Hospitals Seidman Cancer Center
Articles by Amit Mahipal, MD
First-line Atezolizumab With Bevacizumab for HCC
Amit Mahipal, MD
Hepatocellular Carcinoma
|
March 13, 2025
Dr. Amit Mahipal discusses a recent study on atezolizumab plus bevacizumab as a first-line treatment for HCC.
View More
Dr. Amit Mahipal Discusses Liquid Biopsies for Advanced Cholangiocarcinoma at ASCO GI 2024
Amit Mahipal, MD
ASCO GI 2024
|
March 13, 2025
Dr. Amit Mahipal discusses liquid biopsy for advanced cholangiocarcinoma and how it compares to tissue-based testing.
View More
Safety Considerations, Prognostic Factors for Patients with HCC Receiving Lenvatinib After IO
Amit Mahipal, MD
Hepatocellular Carcinoma
|
March 13, 2025
Drs. Mahipal and Finn share the safety and prognostic considerations for patients with aHCC receiving lenvatinib after IO.
View More
Real-world Outcomes for Patients with HCC Receiving Lenvatinib After IO
Amit Mahipal, MD
Hepatocellular Carcinoma
|
March 13, 2025
Drs. Mahipal and Finn discuss real-world outcomes for hepatocellular carcinoma patients receiving lenvatinib following IO.
View More